Compare Otis Worldwide Corp (OTIS) vs Revvity Inc (RVTY) Price & Performance

Otis Worldwide trades at $66.11, up 0.56% today but near its 52-week low, with a bearish technical signal and mixed earnings history. The company reported revenue of $14.43B in 2025 with a net income margin of 10.17%, though recent quarters have seen EPS misses. Analyst consensus is split between Buy and Hold, with a price target of $87.00. News highlights margin pressures from China and labor costs, alongside CEO succession plans for 2027.

The outlook is cautious due to near-term margin headwinds and weak equipment demand, but the service segment's growth and dominant market position offer long-term stability. Risks include China exposure and cost inflation, while institutional buying and a discounted valuation present potential upside if execution improves.

RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.

The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.